Australia's largest stock trading and investment forum Australia's #1 stock forum

PTX

0.00%

3.9¢ prescient therapeutics limited

Daily happenings?., page-303

First 303 Last

Share
Profile

Follow
Lucretious

5,920 Posts.

1830

05/12/23

10:17

Post #: 71273710
Share

Originally posted by BigDaniel: ↑

I personally don't have any expectations that we will have additional responses, if additional responses are announced than that would be fantastic.

I have the expectation that the final readout for the PTX-100 'phase 1B expanded cohort' will generally be a summary of the already known results over the past years.

I think if we see a final readout without any additional icing, the market should not interpret this negatively.

I think we will see traders rubbishing what they do not understand, nor have the need or want to understand...This is my expectation.

I think we will see smart investors recognizing that the PTX-100 results to date, are already superb and likely to see the drug granted straight to a registrational trial in Q1 or early Q2 of 2024.

So if PTX-100 has at the most, maintained it's excellent safety profile (the purpose of phase 1 trials)... I anticipate that when the bath water settles post final readout that the water will steadily rise as a registrational trial is increasingly likely to be approved in the near term.

The cancers that PTX-100 are targeting are very grave, there is an unmet need...A registrational trial will be a big deal for investors, a big deal for patients and cancer sufferers. It should serve as a huge leap for the company and the market cap should reflect this not withstanding the general macro environment outside of our control.

Expand

Totally agree. I am not expecting much other than a restatement of how well the trial has gone. Anything else is icing. this is an opportunity to remind the medical community of PTX100 and Prescient.

The implications and follow through into Q1 2024 with potential FDA developments or partners is what will drive SP

PTX Price at posting: 10.5¢ Sentiment: Buy Disclosure: Held
8 Upvote

0 Great analysis

Reply

Top Stories

The winners & losers on market if negative gearing were gone

NAM

ACCC seeks Olam divestments before it can buy Namoi Cotton

KAL

KalGold rolls out detailed aeromagnetic survey across Pinjin project

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

The market's shrugged at China's stimulus measures all year. Why is this one different?

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

DEG

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

STK

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

ESR

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

There are more pages in this discussion • 231 more messages in this thread...

First 303 Last

Add PTX (ASX) to my watchlist

(20min delay)
Last 3.9¢		Change 0.000(0.00%)		Mkt cap ! $31.40M

Open	High	Low	Value	Volume
3.9¢	4.0¢	3.8¢	$16.31K	421.6K

Buyers (Bids)

No.	Vol.	Price($)
1	47849	3.9¢

Sellers (Offers)

Price($)	Vol.	No.
4.0¢	73928	2

View Market Depth

No.	Vol.	Price($)
1	47849	0.039
5	707297	0.038
8	387500	0.037
5	708916	0.036
3	253590	0.035

Price($)	Vol.	No.
0.040	73928	2
0.041	200000	2
0.042	499154	4
0.043	449950	2
0.045	217151	3

Last trade - 16.10pm 27/09/2024 (20 minute delay)

PTX (ASX) Chart

Daily happenings?., page-303

The winners & losers on market if negative gearing were gone

ACCC seeks Olam divestments before it can buy Namoi Cotton

KalGold rolls out detailed aeromagnetic survey across Pinjin project

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

The market's shrugged at China's stimulus measures all year. Why is this one different?

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Daily happenings?., page-303

Top Stories

The winners & losers on market if negative gearing were gone

ACCC seeks Olam divestments before it can buy Namoi Cotton

KalGold rolls out detailed aeromagnetic survey across Pinjin project

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

The market's shrugged at China's stimulus measures all year. Why is this one different?

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News